We are delighted to announce that the project titled "Development of a New Wound Treatment Strategy Using Exosome-Mediated Drug Delivery System in a Three-Dimensional Biomimetic Chronic Wound Model," led by Prof. Dr. Gülgün Tınaz from the Faculty of Pharmacy at Marmara University, has been awarded support under the TÜBİTAK 1001 Scientific and Technological Research Projects Support Program.

The project will be conducted in collaboration with Marmara University's Nanotechnology and Biomaterials Application and Research Center (NBUAM), Istanbul University-Cerrahpaşa, Yıldız Technical University, Istanbul Technical University, and the Health Biotechnology Excellence Joint Application and Research Center (SABİOTEK). It will span 36 months and involve a team of four researchers and three scholarship students from Marmara University.

In the first phase of the project, for the first time in Turkey, an artificial skin tissue will be created using a 3D bioprinter with live human skin cells and bacterial cells. The goal is to mimic the biofilm produced by bacteria in chronic wound environments, which presents a major obstacle in treating chronic wounds. In the second and final phase, the project aims to develop a new treatment strategy to prevent biofilm formation using a drug delivery system.

We congratulate our esteemed faculty members and the project team and wish them a successful project period.